CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 504 enrolled
Drug / intervention
etafilcon A +1 moredevice
Likely dose
Not stated in record
Key inclusion· 4
  • ✓Age 18 years or older
  • ✓Contact lens prescription between -1.00 to -6.00 D spherical power
  • ✓Less than 1.00 D of astigmatism in either eye
  • ✓Minimum of 7 days of successful prior lens wear experience
Key exclusion· 0

None specified.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00241280
NCT00241280N/ACompleted
CompareCT.gov

Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).

Johnson & Johnson Vision Care, Inc.·interventional·Posted Oct 18, 2005·Updated Mar 24, 2016

In Brief

A clinical study evaluating etafilcon A and galyfilcon A for Myopia. Completed, enrolled 504 participants across 25 sites.

Detailed Summary

Study in the US intended to evaluate the safety and effectiveness of a Johnson \& Johnson Vision Care Inc, (JJVCI) contact lens for use on an extended-wear basis for up to 7 days (6 nights).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 18, 2005
Enrollment StartSep 1, 2005
Primary CompletionOct 1, 2006
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 20.7 years ago

Interventions

etafilcon Adevice

galyfilcon Adevice